FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2774009484> ?p ?o ?g. }

• W2774009484 endingPage "145" @default.
• W2774009484 startingPage "136" @default.
• W2774009484 abstract "This review discusses the rationale, efficacy, and toxicity of a variety of immune approaches being evaluated in the therapy of acute myeloid leukemia (AML) including naked and conjugated monoclonal antibodies, bispecific T-cell engager antibodies, and immune checkpoint blockade via antibodies targeting cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) and programmed-death 1 (PD-1).The stellar success of immune therapies that harness the power of T cells in solid tumors and an improved understanding of the immune system in patients with hematologic malignancies have resulted in major efforts to develop immune therapies for the treatment of patients with AML. Monoclonal antibodies in AML therapy include naked antibodies against AML surface antigens such as CD33 (e.g. lintuzumab) or CD38 (e.g. daratumumab), antibodies conjugated to toxins in various anti-CD33 (gemtuzumab ozogamicin, SGN33A, IMGN779) and anti-CD123 (SL-401, SGN-CD123A) formulations, and antibodies conjugated to radioactive particles such as I or Ac-labeled anti-CD33 or anti-CD45 antibodies. Additional antigenic targets of interest in AML include CLL1, CD38, CD25, TIM3, FLT3, and others. Approaches to harness the body's own T cells against AML include antibodies that recruit and induce cytotoxicity of tumor cells by T cells (bispecific T-cell engager [BiTE] such as CD33 x CD3 (e.g. AMG 330) or CD123 x CD3 (e.g. flotetuzumab, JNJ-63709178) or antibodies that block immune checkpoint receptors CTLA4 (e.g. ipilimumab) or PD1/PD-L1 (e.g. nivolumab, pembrolizumab, avelumab) on T cells, unleashing the patients' T cells against leukemic cells.The ongoing trials and well designed correlative interrogation of the immune system in patients treated on such trials will further enhance our understanding and clinical application of immune therapies as single-agent and combination approaches for the treatment of AML." @default.
• W2774009484 created "2017-12-22" @default.
• W2774009484 creator A5000750846 @default.
• W2774009484 creator A5035605515 @default.
• W2774009484 creator A5045600804 @default.
• W2774009484 creator A5069285537 @default.
• W2774009484 date "2018-03-01" @default.
• W2774009484 modified "2023-09-25" @default.
• W2774009484 title "Immune therapies in acute myeloid leukemia" @default.
• W2774009484 cites W1255676896 @default.
• W2774009484 cites W1763981524 @default.
• W2774009484 cites W1827923022 @default.
• W2774009484 cites W1842764967 @default.
• W2774009484 cites W1906337113 @default.
• W2774009484 cites W1931566397 @default.
• W2774009484 cites W1968949976 @default.
• W2774009484 cites W1971641493 @default.
• W2774009484 cites W1975553571 @default.
• W2774009484 cites W1976105607 @default.
• W2774009484 cites W1976187277 @default.
• W2774009484 cites W1983973479 @default.
• W2774009484 cites W1985043494 @default.
• W2774009484 cites W1992291725 @default.
• W2774009484 cites W1994993231 @default.
• W2774009484 cites W1999822743 @default.
• W2774009484 cites W2000112238 @default.
• W2774009484 cites W2004004651 @default.
• W2774009484 cites W2005401733 @default.
• W2774009484 cites W2008748351 @default.
• W2774009484 cites W2019525376 @default.
• W2774009484 cites W2021588881 @default.
• W2774009484 cites W2025338891 @default.
• W2774009484 cites W2030249962 @default.
• W2774009484 cites W2033577259 @default.
• W2774009484 cites W2033857851 @default.
• W2774009484 cites W2041686632 @default.
• W2774009484 cites W2048797618 @default.
• W2774009484 cites W2058043365 @default.
• W2774009484 cites W2062713220 @default.
• W2774009484 cites W2065406906 @default.
• W2774009484 cites W2065709542 @default.
• W2774009484 cites W2066915867 @default.
• W2774009484 cites W2068046103 @default.
• W2774009484 cites W2071523891 @default.
• W2774009484 cites W2073802053 @default.
• W2774009484 cites W2085162698 @default.
• W2774009484 cites W2087757222 @default.
• W2774009484 cites W2094366129 @default.
• W2774009484 cites W2095012072 @default.
• W2774009484 cites W2111742915 @default.
• W2774009484 cites W2113752195 @default.
• W2774009484 cites W2115091768 @default.
• W2774009484 cites W2115492737 @default.
• W2774009484 cites W2127568389 @default.
• W2774009484 cites W2134061682 @default.
• W2774009484 cites W2135435448 @default.
• W2774009484 cites W2137881702 @default.
• W2774009484 cites W2143748566 @default.
• W2774009484 cites W2146862320 @default.
• W2774009484 cites W2148644851 @default.
• W2774009484 cites W2153310476 @default.
• W2774009484 cites W2210668374 @default.
• W2774009484 cites W2259204994 @default.
• W2774009484 cites W2311562370 @default.
• W2774009484 cites W2356002586 @default.
• W2774009484 cites W2417767096 @default.
• W2774009484 cites W2465734185 @default.
• W2774009484 cites W2514457877 @default.
• W2774009484 cites W2531198037 @default.
• W2774009484 cites W2559908363 @default.
• W2774009484 cites W2560829310 @default.
• W2774009484 cites W2583358631 @default.
• W2774009484 cites W2591709377 @default.
• W2774009484 cites W2594298520 @default.
• W2774009484 cites W2596753223 @default.
• W2774009484 cites W2757788013 @default.
• W2774009484 cites W2890113688 @default.
• W2774009484 cites W4230744147 @default.
• W2774009484 cites W4231346141 @default.
• W2774009484 doi "https://doi.org/10.1097/moh.0000000000000401" @default.
• W2774009484 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29206680" @default.
• W2774009484 hasPublicationYear "2018" @default.
• W2774009484 type Work @default.
• W2774009484 sameAs 2774009484 @default.
• W2774009484 citedByCount "65" @default.
• W2774009484 countsByYear W27740094842018 @default.
• W2774009484 countsByYear W27740094842019 @default.
• W2774009484 countsByYear W27740094842020 @default.
• W2774009484 countsByYear W27740094842021 @default.
• W2774009484 countsByYear W27740094842022 @default.
• W2774009484 countsByYear W27740094842023 @default.
• W2774009484 crossrefType "journal-article" @default.
• W2774009484 hasAuthorship W2774009484A5000750846 @default.
• W2774009484 hasAuthorship W2774009484A5035605515 @default.
• W2774009484 hasAuthorship W2774009484A5045600804 @default.
• W2774009484 hasAuthorship W2774009484A5069285537 @default.
• W2774009484 hasConcept C147483822 @default.
• W2774009484 hasConcept C154317977 @default.

• next